Amunix Pharmaceuticals

South San Francisco, California, United States

Therapeutics Drug Development Biotech Cancer

Amunix Pharmaceuticals, based in Mountain View, CA, is focused on developing prodrugs to bring the promise of potent immune-activating biotherapeutics to patients with solid tumor cancers. The company is leveraging its proprietary T cell engager (XPAT) and cytokine (XPAC) platforms to advance a pipeline of novel prodrugs that are selectively activated in the tumor microenvironment. Both platforms utilize Amunix’s prodrug technology that has been clinically validated to extend drug half-life with limited immunogenicity. Amunix is advancing its lead development candidate, AMX-818, an XPAT T cell engager targeting HER2+ solid tumors, toward the clinic, and has several discovery programs underway. By delivering breakthrough therapies that can safely harness the immune system, we aim to conquer cancer and save lives.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Amunix Pharmaceuticals on @MedStartr Today #SolidTumors #Therapeutics #DrugDevelopment #Biotech #Cancer #MedMo #MedStartrVentures

https://www.medstartr.ai/s/KBDhxrhFjwM

Get Involved in Amunix Pharmaceuticals

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2006
Website: www.amunix.com/

Disease Areas

Solid Tumors

Technologies

BiotherapeuticsDrug DevelopmentPlatformTargeted Therapeutics

🌐Website

What do you think of Amunix Pharmaceuticals?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.